latest news releases from the newsroom
Scottish Power PLC
ScottishPower Buys Damhead Creek Power Station
GLASGOW, U.K., June 2, 2004 (PRIMEZONE) -- ScottishPower is pleased to announce the purchase of the 800MW Damhead Creek CCGT power plant and associated contracts, including the benefit of a long-term gas supply agreement, from its creditor banks for approximately GBP317 million in cash.
Murray, Frank & Sailer LLP
Murray, Frank & Sailer LLP Announces a Class Action Lawsuit Against Krispy Kreme Doughnuts, Inc. on Behalf of Shareholders -- KKD
NEW YORK, June 1, 2004 (PRIMEZONE) -- Murray, Frank & Sailer LLP announces a class action lawsuit on behalf of purchasers of the securities of Krispy Kreme Doughnuts, Inc. ("Krispy Kreme" or the "Company") (NYSE:KKD) between August 21, 2003 and May 7, 2004, inclusive (the "Class Period"). The action is for remedies under the Securities Exchange Act of 1934 (the "Exchange Act").
Quintek Technologies, Inc.
FedEx Kinko's Selects Quintek Services, Inc. (QSI) as Western Region Document Scanning Partner of Choice
SAN DIEGO, June 1, 2004 (PRIMEZONE) -- Craig Hath, FedEx Kinko's Regional Vice President, California, announced today that FedEx Kinko's, a division of FedEx Corp. (NYSE:FDX) has selected Quintek Services, Inc. (QSI), a wholly owned subsidiary of Quintek Technologies, Inc. (OTCBB:QTEK) as their preferred Document Imaging & Document Scanning partner for Kinko's Western Region. QSI is a full service solution provider of Document Scanning Services and Business Process Outsourcing (BPO). Quintek's Senior Leadership Team has over 50 years experience in delivering Digital Scanning and Electronic Document Imaging Solutions to Corporate America at the Departmental and Enterprise levels.
Superclick, Inc. Expands Footprint in Burgeoning Multi-Tenant Unit Market with Leading Solutions Provider
LAGUNA HILLS, Calif., June 1, 2004 (PRIMEZONE) -- Superclick, Inc. (OTCBB:SPCK) announced today that it has been selected by Building Technologies, a leading technology solutions provider to the Multi-Tenant Unit (MTU) market, to provide high-speed Internet access to twelve of its properties, reaching an addressable 6,000 apartments. Under the terms of its agreement with Building Technologies, Superclick will provide Building Technologies with the Internet platform and tools needed to provide and manage all aspects of Building Technologies' Internet products to its customers.
Discovery Laboratories, Inc.
Mark G. Osterman Joins Discovery Laboratories as Senior Vice President, Sales and Marketing
DOYLESTOWN, Pa., June 1, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced the appointment of Mark G. Osterman as Senior Vice President, Sales and Marketing. Reporting directly to the Chief Executive Officer, Mr. Osterman will be the most senior executive responsible for developing, executing and managing Discovery's commercial operations, including the commercial responsibilities of Discovery's strategic partners. Mr. Osterman's initial assignment will be to execute the potential launch of Discovery's lead product, Surfaxin(R) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants.
Complaint against Q-Med filed by Inamed
UPPSALA, Sweden, June 1, 2004 (PRIMEZONE) -- Q-Med today announced that the Company has obtained information that Inamed Corporation has filed a request that the U.S International Trade Commission commence an investigation pursuant to Section 337 of the Tariff Act of 1930 against Q-Med and Medicis Aesthetics, Inc., a wholly-owned subsidiary of Medicis Pharmaceutical Corporation, regarding an allegation of infringement of Inamed's U.S. Patent No. 4,803,075 dated February 7, 1986 by the dermal filler, RESTYLANE(R). The Company has also obtained information that Inamed has filed an infringement action against Q-Med and Medicis in the U.S. District Court for the Southern District of California regarding the same patent. After a preliminary investigation regarding the above-referenced complaints, it is Q-Med's and Medicis' belief that they have meritorious defenses as to the infringement claims and the validity of the Inamed patent.